TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 93 filers reported holding TCR2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,000 | -45.2% | 35,135 | -7.7% | 0.00% | – |
| Q4 2021 | $177,000 | -46.2% | 38,067 | -1.6% | 0.00% | – |
| Q3 2021 | $329,000 | -46.2% | 38,684 | +3.9% | 0.00% | -100.0% |
| Q2 2021 | $611,000 | -24.9% | 37,249 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $814,000 | -28.7% | 36,874 | -0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,141,000 | +84.3% | 36,884 | +21.1% | 0.00% | +100.0% |
| Q3 2020 | $619,000 | +81.0% | 30,451 | +36.8% | 0.00% | 0.0% |
| Q2 2020 | $342,000 | +260.0% | 22,260 | +80.4% | 0.00% | – |
| Q1 2020 | $95,000 | -39.9% | 12,338 | +11.5% | 0.00% | – |
| Q4 2019 | $158,000 | -2.5% | 11,068 | +2.6% | 0.00% | – |
| Q3 2019 | $162,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |